ReWalk Robotics (RWLK) Getting Somewhat Favorable News Coverage, Study Finds
Media stories about ReWalk Robotics (NASDAQ:RWLK) have trended somewhat positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ReWalk Robotics earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave media stories about the medical device company an impact score of 46.2976972222593 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Shares of ReWalk Robotics (NASDAQ:RWLK) traded up $0.17 during mid-day trading on Tuesday, reaching $1.55. 1,314,300 shares of the company’s stock traded hands, compared to its average volume of 350,974. The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02. ReWalk Robotics has a twelve month low of $1.10 and a twelve month high of $3.60.
ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings data on Thursday, November 2nd. The medical device company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.10. The business had revenue of $1.70 million for the quarter, compared to analyst estimates of $1.63 million. ReWalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The company’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.62) earnings per share. research analysts predict that ReWalk Robotics will post -1.14 earnings per share for the current year.
Several analysts have commented on RWLK shares. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research report on Thursday, November 9th. Canaccord Genuity reaffirmed a “buy” rating and issued a $3.00 price objective on shares of ReWalk Robotics in a research report on Monday, November 6th. Jefferies Group LLC lowered their price objective on shares of ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 3rd. Finally, Oppenheimer Holdings, Inc. set a $4.00 price objective on shares of ReWalk Robotics and gave the stock a “buy” rating in a research report on Friday, August 4th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company. ReWalk Robotics has a consensus rating of “Buy” and a consensus target price of $3.00.
TRADEMARK VIOLATION NOTICE: “ReWalk Robotics (RWLK) Getting Somewhat Favorable News Coverage, Study Finds” was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2017/11/14/rewalk-robotics-rwlk-getting-somewhat-favorable-news-coverage-study-finds.html.
About ReWalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.